Moreover, AKR1C1 overexpression correlates with drug resistance in some cancer cell lines to chemotherapy in vitro (Wang et al., 2007; Bortolozzi et al., 2018; Chang et al., 2019). The gene discussed is AKR1C1; the disease is cancer.